> 数据图表如何了解2025年创新药板块复盘2025-12-22025年创新药板块复盘 按营业收入排序，A股TOP5公司为华东医药、复星医药、百济神州、恒瑞医药、百利天恒和人福医药。营业收入超过100亿元的公司共计7家。 港股研发费用TOP5公司（根据2025H1数值排序）为复星医药、中国生物制药、百济神州、恒瑞医药和石药集团。营收超100亿公司共计5家。A股、H股药企营业收入TOP20（亿元）-按收入排序A股202320242025Q3YTDH股202320242025H1公司名称华东医药复星医药百济神州-U恒瑞医药人福医药科伦药业健康元长春高新丽珠集团华润双鹤海正药业华海药业恩华药业亿帆医药艾力斯康弘药业海思科信立泰京新药业甘李药业市值7397254,3034,090304539231407323195127269250154433286674674164380营业收入营业收入营业收入406.2414.0174.2228.2245.2214.5166.5145.7124.3102.2100.583.150.440.720.239.633.633.740.026.1419.1410.7272.1279.8254.4218.1156.2134.7118.1112.1103.495.557.051.635.644.537.240.141.630.5326.6293.9276.0231.9178.8132.8114.898.191.282.879.264.144.739.237.336.233.032.430.530.5公司名称复星医药中国生物制药百济神州恒瑞医药石药集团联邦制药翰森制药丽珠医药信达生物远大医药三生制药康哲药业先声药业绿叶制药复宏汉霖长江生命科技和黄医药再鼎医药康方生物映恩生物-B市值598.31336.02767.35108.21002.5247.52002.3284.81469.7271.2624.1310.0296.0124.4355.386.0197.0259.01076.4236.9营业收入营业收入营业收入412.5262.0174.1228.2314.5137.4101.0124.362.195.478.280.166.161.453.948.259.418.945.317.9409.1288.7273.9279.8290.1137.6122.6118.194.2107.891.174.766.460.657.251.145.328.721.219.4194.3175.7174.1157.6132.775.274.362.759.555.743.640.035.831.828.223.819.915.514.112.3数据来源：Wind，西南证券整理；注：统计至2025年12月5日57西南证券健康医疗
